Gamma-aminobutyric acid (GABA)-mediated bone formation and its implications for anti-osteoporosis strategies: Exploring the relation between GABA and GABA receptors.

MLA

Arachchilage Hasitha Maduranga Karunarathne, Wisurumuni, et al. “Gamma-Aminobutyric Acid (GABA)-Mediated Bone Formation and Its Implications for Anti-Osteoporosis Strategies: Exploring the Relation between GABA and GABA Receptors.” Biochemical Pharmacology, vol. 218, Dec. 2023, p. 115888. EBSCOhost, https://doi.org/10.1016/j.bcp.2023.115888.

APA

Arachchilage Hasitha Maduranga Karunarathne, W., Hyun Choi, Y., Lee, M.-H., Kang, C.-H., & Kim, G.-Y. (2023). Gamma-aminobutyric acid (GABA)-mediated bone formation and its implications for anti-osteoporosis strategies: Exploring the relation between GABA and GABA receptors. Biochemical Pharmacology, 218, 115888. https://doi.org/10.1016/j.bcp.2023.115888

Chicago

Arachchilage Hasitha Maduranga Karunarathne, Wisurumuni, Yung Hyun Choi, Mi-Hwa Lee, Chang-Hee Kang, and Gi-Young Kim. 2023. “Gamma-Aminobutyric Acid (GABA)-Mediated Bone Formation and Its Implications for Anti-Osteoporosis Strategies: Exploring the Relation between GABA and GABA Receptors.” Biochemical Pharmacology 218 (December): 115888. doi:10.1016/j.bcp.2023.115888.